A Pennsylvania mall that was foreclosed on after its owners failed to repay $143 million has been auctioned off for $100. Wells Fargo Bank was owed the money from a 2006 loan and submitted the winning bid for the 1.1 million-square-foot Galleria at Pittsburgh Mills on Wednesday.
Shares of Pfizer (PFE) continue to struggle after testing heavy resistance just below $34. In November, the stock left behind an ugly post-election spike high just shy of this level. This month the same key zone, which includes Pfizer's 200-day moving average, has proven to be a major roadblock. After leaving behind back-to-back weekly highs near this month's top, Pfizer faces rising overhead pressure. With Tuesday's nearly 2% drop, Pfizer stock is now off by more than 5% from the January peak and is now well below last week's low. This steep pullback may soon need a rest, but further downside is likely. For patient investors, continued downside will create a very low-risk entry opportunity.
If it seems like the stock market's crawl to nowhere over the past month has been particularly strange, that's because it has been. It turns out the gap between the Dow's high and low prices over the past month is a tiny 1.4 percent — the narrowest gap in data going back to 1957. It was just over a month ago, on Dec. 13, when we saw the Dow Jones industrial average cross 19,900 for the first time. Since then, we've seen an intraday high of 19999.63 and a low of 19719.67. The gap between those two levels is only 1.4 percent. The Dow's entire past month has stayed within that extremely tight range. To put this in perspective: We usually see a 6 to 7 percent average range in a typical month. In